The Designed Ankyrin Repeat Protein Antiviral Ensovibep for Nonhospitalized Patients With Coronavirus Disease 2019: Results From EMPATHY, a Randomized, Placebo-Controlled Phase 2 Study
Kingsley et al., Open Forum Infectious Diseases, doi:10.1093/ofid/ofae233
https://c19early.org/kingsley.html